Author

A. Carnero

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1 Approach:biophysical modeling· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

E. M. Verdugo-Sivianes· 2 shared S. Munoz-Galvan· 2 shared A. Carracedo· 1 shared B. Felipe-Abrio· 1 shared C. Fernandez-Rozadilla· 1 shared E. Suarez-Martinez· 1 shared J. M. Garcia-Heredia· 1 shared J. M. Santos-Pereira· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. M. Verdugo-Sivianes

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors

S. Munoz-Galvan, E. M. Verdugo-Sivianes, J. M. Santos-Pereira, P. Estevez-Garcia, A. Carnero

This study identifies PLD2 as a mediator of hypoxia-induced stemness and chemoresistance in ovarian cancer, proposing PLD2 inhibition as a potential therapeutic strategy.

bioRxiv · Jul 19, 2023Cancer Biology

Identification of a minimal biomarker profile in head-and-neck squamous cell carcinoma tumors

L. Sanchez-Diaz, L. E. Navas, E. Suarez-Martinez, B. Felipe-Abrio, C. Fernandez-Rozadilla, E. M. Verdugo-Sivianes, M. A. Celis-Romero, M. Chaves-Conde, M.-D. Chiara, Y. Garcia-Mayea, M. E. LLeonart, J. M. Garcia-Heredia, S. Munoz-Galvan, A. Carracedo, J. P. Rodrigo, A. Carnero

The paper identifies three genes, WDR66, SERPINH1, and ZNF622, as a minimal biomarker signature for predicting prognosis in head-and-neck squamous cell carcinoma.

bioRxiv · Nov 12, 2021 · PreprintCancer Biology